Summary: S.252 — 115th Congress (2017-2018)All Information (Except Text)

There is one summary for S.252. Bill summaries are authored by CRS.

Shown Here:
Introduced in Senate (02/01/2017)

Medicare Drug Savings Act of 2017

This bill requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services (CMS) for prescription drugs dispensed to eligible low-income individuals under the Medicare prescription drug benefit or a Medicare Advantage (MA) prescription drug plan (PDP).

Subject to civil monetary penalties, a Medicare or MA PDP sponsor must report, both to drug manufacturers and to the CMS, specified information related to the determination and payment of such rebates.